Credit: Getty Images. Extrapyramidal symptoms that developed in patients with schizophrenia after initiation of treatment with atypical antipsychotic agents were associated with increased healthcare ...
This study presents a meta-analysis of the influence of several potentially biasing factors (eg industry support, extrapyramidal side effects) on efficacy of studies comparing second-generation ...
Prior research found EPS to be dose related, 17 and patients with schizophrenia, who require higher doses of antipsychotics, 17 demonstrate greater susceptibility to EPS. 3,18 Because APAs are ...
For patients with schizophrenia, long-acting injectable antipsychotics (LAIAs) are associated with a lower risk than oral antipsychotics (OAs) for disease relapse and hospitalization ― and they carry ...
The primary finding of this study is that prescriptions for anticholinergics were documented in 21% of children and adolescents receiving antipsychotics for various psychiatric disorders. Utilization ...
In every state across America, Medicaid programs are under serious budgetary pressure. The need to contain costs has led to various forms of restriction in the coverage for drug therapy, including ...
This case highlights vitamin E’s potential as an effective adjunct treatment for patients with antipsychotic-induced motor symptoms resistant to standard therapies. Vitamin E has shown significant ...
New research illuminates the benefits and risks of antipsychotic medication in children and its impact on individual well-being, social, educational and/or vocational functioning, and disease burden.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback